Toxoplasma gondii in Wildlife: Impact on Conservation and One Health

Introduction

Toxoplasma gondii is an obligate intracellular apicomplexan parasite with a global distribution, capable of infecting virtually all warm-blooded vertebrates. The definitive hosts are felids, which shed environmentally resistant oocysts, while intermediate hosts include a wide array of mammals and birds. In wildlife, T. gondii infection can range from asymptomatic seroconversion to acute fatal disease, particularly in naive or immunocompromised species. The parasite's ability to persist as tissue cysts and its environmental resilience make it a persistent threat to conservation efforts and a key component of the One Health paradigm linking wildlife, domestic animals, and human populations.

This review synthesizes recent peer-reviewed literature on the seroprevalence of T. gondii in sentinel wildlife species, the spillover of infection to endangered populations, and the mechanisms by which environmental contamination perpetuates zoonotic risk. The discussion emphasizes the application of molecular diagnostics, ecological surveillance, and computational modeling in understanding and mitigating these impacts.

Life Cycle and Transmission in Wildlife

The life cycle of T. gondii is characterized by three infectious stages: sporozoites (within oocysts), tachyzoites, and bradyzoites (within tissue cysts). Felids excrete unsporulated oocysts in feces; sporulation occurs in the environment over 1 to 5 days, yielding oocysts that remain infective for months to years under temperate conditions. Intermediate hosts acquire infection primarily through ingestion of sporulated oocysts from contaminated soil, water, or vegetation, or through consumption of tissue cysts in infected prey.

Wildlife can serve as both intermediate hosts and, in the case of wild felids, as definitive hosts. The parasite's broad host range and the long-term persistence of oocysts in soil and water create a complex transmission network. Studies on the deubiquitinase activity of TgJosephin and TgRad23 [1] have elucidated molecular mechanisms that enable T. gondii to subvert host interferon-gamma responses, facilitating chronic infection in intermediate hosts. Furthermore, the effector GRA35 mediates neuronal damage through endoplasmic reticulum stress and mitochondria-associated apoptosis [2], a pathway of particular concern for species with high neural vulnerability.

Sentinel Species and Seroprevalence

Sentinel species provide early warning signals of environmental contamination and pathogen circulation. Seroprevalence surveys in wildlife have been instrumental in mapping the ecological niche of T. gondii. A longitudinal study [3] highlighted the challenges of interpreting seroprevalence data for a chronic parasitic infection, emphasizing that antibody titers may fluctuate and do not always correlate with active infection or tissue cyst burden.

Avian Sentinel Species

Birds, especially those foraging on the ground or in aquatic environments, are highly exposed to oocysts. In a serosurvey of wild birds in Lahore, Pakistan [4], high seroprevalence was detected, with risk factors including proximity to felid populations and access to untreated water. Wild birds can also act as mechanical vectors, dispersing oocysts over large distances.

Mammalian Sentinel Species

Rodents and lagomorphs are classic sentinels due to their small home ranges and direct exposure to soil contamination. A review of rodent-borne pathogens [5] underscored the economic and zoonotic threat that T. gondii poses to livestock farming, as synanthropic rodents bridge wildlife and domestic environments. In urban settings, pharmaceutical pollutants in rats have been linked to an increased zoonotic infection risk [6], potentially through immunosuppression or behavioral changes that enhance exposure to oocysts.

Deer species serve as useful bioindicators of landscape-level contamination. In Erbil, Iraq, serological investigation of local deer [7] revealed a substantial prevalence of T. gondii, confirming the parasite's circulation in peri-urban ecosystems.

Nonhuman Primates and Wild Felids

Nonhuman primates and wild felids are sentinel species with dual relevance: felids amplify the parasite, while primates are highly susceptible to clinical disease. A Brazilian zoo study [8] employed nonhuman primates and wild felines as environmental bioindicators, demonstrating that seropositivity in these groups correlates with oocyst contamination in the enclosure environment. This approach combines conservation monitoring with zoonotic risk assessment.

Table 1 summarizes seroprevalence findings across representative wildlife groups.

Table 1. Seroprevalence of Toxoplasma gondii in Selected Wildlife Species

Spillover to Endangered Wildlife

Acute toxoplasmosis is a significant cause of mortality in naive or endangered species. Fatal toxoplasmosis in free-ranging Colombian night monkeys (Aotus lemurinus) from a peri-urban area of Cali, Colombia [9] exemplifies a spillover event where oocyst contamination from domestic cats entered a wild primate population. Clinical findings included necrotizing encephalitis, myocarditis, and multifocal necrosis, with molecular confirmation of T. gondii DNA.

Zoo collections are particularly vulnerable because captive animals often lack prior exposure. The study by Andrade et al. [8] reported that both nonhuman primates and felids in a Brazilian zoo showed high antibody titers, indicating ongoing exposure. Management strategies must therefore include strict hygiene protocols, exclusion of feral cats from enclosures, and periodic serological screening of vulnerable species.

Host Susceptibility and Virulence Factors

The outcome of infection in wildlife depends on host genetics, immune status, and parasite strain. Research on the effector GRA35 [2] demonstrated that this protein promotes neuronal damage through ER stress and apoptosis, which is especially detrimental to species with small population sizes. Additionally, the deubiquitinase TgJosephin and its cofactor TgRad23 [1] are essential for virulence by stabilizing the serine protease SPM1, which degrades immunity-related GTPases. These molecular insights help explain the variable pathogenicity observed across different wildlife hosts.

Environmental Contamination and One Health Implications

T. gondii oocysts are exceptionally resilient; they can survive in moist soil for over a year and in seawater for several months. This environmental persistence creates a continuous source of infection for wildlife, livestock, and humans.

Waterborne and Soilborne Transmission

Contamination of water sources with oocysts from felid feces is a major route for human infection, particularly in developing regions. Wildlife, through their defecation patterns and movement, can also contribute to the spread of oocysts. The role of urban rats as sentinels of pharmaceutical pollutants [6] illustrates how anthropogenic environmental changes can modulate zoonotic risk: pollutants may impair immune function, increasing parasite burden and shedding in reservoir hosts.

Risk to Veterinary Professionals and Indigenous Communities

Occupational exposure to T. gondii is documented among veterinary professionals and students. A seroprevalence study in Aguascalientes, Mexico [10] reported higher infection rates among individuals with direct animal contact, emphasizing the need for protective measures. In indigenous communities where dogs and wildlife coexist, as investigated by Galvão et al. [11], serological surveys in dogs provide a window into environmental contamination levels and zoonotic risk.

One Health Surveillance Framework

An integrated surveillance approach combines wildlife serology, domestic animal monitoring, and environmental sampling. The Mermaid diagram below illustrates the core surveillance pathway using diagnostic data to guide interventions.

flowchart TD
    A[Environmental Sampling: Soil, Water, Feces], > B[Oocyst Detection: Microscopy, qPCR]
    B, > C{Risk Assessment}
    C, > D[Low Risk: Routine Monitoring]
    C, > E[Moderate Risk: Enhanced Surveillance + Wild/Feral Cat Management]
    C, > F[High Risk: Immediate Intervention: Exclusion, Vaccination if available, Public Advisory]
    A, > G[Sentinel Species Sampling: Birds, Rodents, Deer, Primates]
    G, > H[Serological Screening: ELISA, IFAT, MAT]
    H, > I[Confirmatory PCR from Blood/Tissue]
    I, > C
    G, > J[Clinical Case Detection: Necropsy, Histopath, Molecular Diagnostics]
    J, > C

This framework supports adaptive management in conservation areas and peri-urban zones.

Diagnostic Approaches for Wildlife

Accurate diagnosis in wildlife requires methods adapted to field conditions and sample preservation. Filter paper blood preservation is a cost-effective technique for tropical field studies. Menajovsky et al. [12] evaluated the stability of anti-T. gondii antibodies in filter paper-preserved blood, demonstrating that ELISA and IFAT remain reliable for at least 60 days post-collection even under elevated temperature and humidity. This approach facilitates large-scale serosurveys without cold chain logistics.

For definitive diagnosis of clinical cases, histopathology coupled with PCR targeting the B1 gene or 529 bp repetitive element is the gold standard. Commercial ELISA kits (using generic terms) are available for many species, but cross-reactivity with closely related parasites such as Neospora caninum must be ruled out, as noted in co-infection studies [7, 11].

Molecular Mechanisms of Virulence and Potential Therapeutic Targets

Several recent studies have identified key molecular determinants of T. gondii pathogenesis that could inform wildlife vaccine development. Sun et al. [13] demonstrated that prophylactic administration of Gypsophila oldhamiana extract restricts acute infection in a murine model via the DC-IL-12-CD8+ T cell axis, suggesting a potential plant-derived immunomodulatory strategy for wildlife applications.

Conversely, the parasite's own molecular machinery offers intervention targets. Loss of glutaredoxin 5 (TGME49_227100) disrupts oocyst formation and sporulation [14], providing a genetic target for blocking environmental contamination. Additionally, the gut microbiota metabolite N-acetyl-D-glucosamine has been shown to alleviate systemic inflammatory responses during acute infection [15], highlighting the role of the host microbiome in modulating disease outcome.

Impact on Livestock and Domestic Animal Health

Wildlife serves as a reservoir for infection of domestic animals, with economic consequences for livestock farming. Rodent-borne T. gondii poses a threat to livestock through feed contamination [5]. In dogs living in indigenous communities, seropositivity correlates with higher risk of environmental oocyst contamination [11]. Such findings reinforce the need for a One Health approach that integrates wildlife management, livestock biosecurity, and companion animal health.

Conclusion

Toxoplasma gondii in wildlife represents a persistent challenge for conservation biology and public health. Sentinel species, including birds, rodents, deer, and primates, provide critical data on environmental contamination. Spillover to endangered species can result in fatal disease, as seen in Colombian night monkeys. Environmental oocyst contamination from both domestic and wild felids perpetuates the cycle, posing zoonotic risks to humans through water, soil, and foodborne pathways. The integration of molecular diagnostics, serological surveillance, and computational modeling within a One Health framework is essential for effective monitoring and mitigation. Future directions should include the development of wildlife-safe vaccines and environmental interventions targeting oocyst biology, informed by ongoing research into parasite virulence mechanisms.

References

[1] Hashizaki E, Tachibana Y, Fukumoto J, et al. TgJosephin and TgRad23 are important for anti-IFN-y virulence via deubiquitination of SPM1 in Toxoplasma. mSphere. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41972766/

[2] Wang J, Chen Y, Zhou N, et al. Toxoplasma gondii effector GRA35 mediates neuronal damage via ER stress and mitochondria-associated apoptosis. Virulence. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41940502/

[3] Bancroft KL, Meyer CJ, Jenkins EJ, et al. Toxoplasma gondii: Challenges and Perspectives in Interpreting Longitudinal Seroprevalence Data for a Chronic Parasitic Infection. J Wildl Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42161386/

[4] Ali S, Imran F, Lilak AA, et al. Seroprevalence and Risk Analysis of Toxoplasma Gondii in Wild Birds of District Lahore Punjab, Pakistan. Vet Med Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41961177/

[5] Huels F, Jacob J. Rodent-borne pathogens as economic and zoonotic health threat to livestock farming: a review. One Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42206021/

[6] Sundberg AJ, Cerveny D, Costa F, et al. Pharmaceutical Pollutants in Urban Rats Are Linked to Zoonotic Infection Risk. Environ Sci Technol Lett. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42145584/

[7] Aziz KJ, Mikaeelb FB, Nasrullah OJ, et al. Seroepidemiological investigation of Toxoplasma gondi and Neospora caninum in local Deers in Erbil, Iraq. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42034957/

[8] Andrade ACS, Vieira FPR, Dos Santos IC, et al. Nonhuman Primates and Wild Felines as Environmental Bioindicators of Toxoplasma gondii and Leishmania Spp. from a Brazilian Zoo. Vector Borne Zoonotic Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41879174/

[9] Alves MH, Buitrago DI, Henao-Duque AM, et al. Fatal toxoplasmosis in free-ranging Colombian night monkeys (Aotus lemurinus) from a peri-urban area of Cali, southwestern Colombia. Vet Parasitol Reg Stud Reports. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42034963/

[10] de Velasco-Reyes I, Torres-Garcia SE, Hernandez-Rangel JJ, et al. Seroprevalence of Toxoplasma gondii Infection in Veterinary Medicine Professionals and Students in Aguascalientes, Mexico. Epidemiologia (Basel). 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42201205/

[11] Galvao CMMQ, Leite DPSBM, Oliveira PRF, et al. First serological investigation of Toxoplasma gondii, Neospora caninum, Leishmania infantum and Leptospira spp. in dogs from a Fulni-o Indigenous community in Pernambuco, Brazil: a One Health perspective. Braz J Biol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41849483/

[12] Menajovsky MF, Ulloa GM, Fa JE, et al. Assessing antibody stability in filter paper-preserved blood samples for wildlife disease surveillance in tropical forests. Res Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41875629/

[13] Sun P, Kim Y, Kim J, et al. Prophylactic Administration of Gypsophila oldhamiana Extract Restricts Acute Toxoplasma gondii Infection via the DC-IL-12-CD8+ T Cell Axis in a Murine Model. Acta Parasitol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42250127/

[14] Xie F, Xie Y, Yang Y, et al. Loss of TGME49_227100 (Glutaredoxin 5) Disrupts Oocyst Formation and Sporulation in Toxoplasma gondii. Pathogens. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41754403/

[15] Yang Y, Zhou C, Yang C, et al. Gut microbiota-associated metabolite N-acetyl-D-glucosamine alleviates systemic inflammatory responses induced by acute Toxoplasma gondii infection. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41824485/